Depreciation, Depletion and Amortization of Sunshine Biopharma Inc. from 31 Mar 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Sunshine Biopharma Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Mar 2015 to 31 Mar 2025.
  • Sunshine Biopharma Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $64,793, a 52% increase year-over-year.
  • Sunshine Biopharma Inc. annual Depreciation, Depletion and Amortization for 2024 was $223,527, a 50% increase from 2023.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Sunshine Biopharma Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $64,793 +$22,175 +52% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $42,618 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2016 $15,244 +$15,244 01 Jan 2016 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q1 2015 $0 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1

Sunshine Biopharma Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $223,527 +$74,380 +50% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 $149,147 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.